학술논문

Neoadjuvant docetaxel (T), carboplatin (C), with or without trastuzumab (H) for T3 and T4 breast cancer.
Document Type
Journal
Source
JOURNAL OF CLINICAL ONCOLOGY; JUN 1 2005, 23 16, p89S-p89S, 1p. Supplement: S
Subject
Language
English
ISSN
15277755